Authors:
VERMORKEN JB
CLAESSEN A
GALL H
VANHOLTEN A
VANTINTEREN H
MEIJER S
STEFFELAAR H
BRAKENHOFF J
VANBOCHOVE A
SCHEPER R
MEIJER C
HANNA M
PINEDO H
Citation: Jb. Vermorken et al., RANDOMIZED PHASE-III TRIAL OF ACTIVE SPECIFIC IMMUNOTHERAPY (ASI) VERSUS CONTROL IN PATIENTS WITH DUKES B2, B3 OR C COLON-CANCER, European journal of cancer, 33, 1997, pp. 722-722